. Peptide antigens linked to self-assembling domains are more effectively presented by DCs compared to soluble antigen. IL-2 production by BB7 cells (T cells recognizing the Ag85B epitope) presented on BCG-infected DCs treated with KFE8-Ag85B is significantly higher compared to soluble Ag85B at two different doses tested (n=2 replicates/group). Figure S2 . Enhanced antigen-presentation and higher IL-2 production is observed in macrophages treated with KFE8-Ag85B compared to macrophages treated with soluble Ag85B peptide even without BCG infection (n=4 replicates/group). . *p<0.05 by students t-test (n=3 replicates/group). Figure S3 . Addition of autophagy inhibitors 3-MA and bafilomycin leads to reduced IL-2 production by macrophages treated with KFE8-Ag85B. A reduction in IL-2 levels was also observed in macrophages treated with soluble Ag85B peptide in the presence of bafilomycin (n=2 replicates/group). Figure S4 . Antigenic-processing and presentation of self-assembling peptide nanofibers by DCs involves autophagy. Data demonstrating that IL-2 production is significantly reduced in Atg7-/-DCs treated with KFE8-Ag85B nanofibers and overlaid with BB7 cells. Interestingly, Atg7-/-DCs treated with soluble Ag85B also exhibited similar behavior. *p<0.05 by students t-test (n=3 replicates/group). Figure S5 . Data demonstrating higher IL-2 production in MФs treated with NapFFK-Ag85B nanofibers compared to soluble antigen Ag85B and significant reduction of IL-2 in Atg5-/-MФs treated with NapFFK-Ag85B nanofibers. *p<0.05 by students t-test (n=3 replicates/group). Figure S6 . Nanofibers of KFE8 (A) and KFE8-OVA (B) as observed using TEM. Scale bar = 100 nm. Circular dichrosim spectra of KFE8 and OVA-KFE8 indicating transition from a crossbeta structure to pure beta-sheet (C). Peptide concentration was 0.75 mM in ultrapure water. 
